文献速递免疫规划

利用肠道环境介导的宿主免疫调控系统开发疫苗佐剂

Utilization of gut environment-mediated control system of host immunity in the development of vaccine adjuvants.
PubMed 文献 · Vaccine · 2022-07-30

本文综述了共生细菌及饮食成分等肠道环境因素调控宿主免疫的机制,指出特定微生物源化合物具有佐剂潜力,并探讨将其开发为疫苗佐剂的可能性。

要点

  • 肠道共生菌及饮食成分可介导宿主免疫应答。
  • 特定微生物源化合物具有佐剂潜力。
  • 综述提出将这些化合物用作疫苗佐剂。

核心结论

  • 肠道环境相关免疫调控研究揭示了特定微生物源化合物作为疫苗佐剂的潜力,作者提出其潜在应用。

研究设计与样本

  • 综述,未报告检索范围。

主要发现

  • 共生细菌及其衍生化合物可调控宿主免疫应答。

临床怎么用

  • 作者提出这些化合物作为疫苗佐剂的潜在应用,原文未据此给出临床推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vaccination is one of the most powerful strategies for the preventive and therapeutic control of infectious diseases and other diseases such as cancer. To maximize the effectiveness of vaccines, it is necessary to modify the immune responses by means of adjuvants. The gut environment, including commensal bacteria and dietary components, has been proven to be able to mediate host immunity. An understanding of gut microbiota-related regulation of immune responses has revealed the potential adjuvanticity of particular microbiota-derived compounds, driving exploration into their development as vaccine adjuvants. In this review, we discuss how commensal bacteria and compounds derived from them regulate host immune responses, and we propose the potential application of these compounds as vaccine adjuvants.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Liu Z, Hosomi K, Kunisawa J, et al. Utilization of gut environment-mediated control system of host immunity in the development of vaccine adjuvants. Vaccine. 2022. PMID: 35918205. doi:10.1016/j.vaccine.2022.07.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。